Silvia Rollefstad

3.5k total citations
60 papers, 1.2k citations indexed

About

Silvia Rollefstad is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Silvia Rollefstad has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 19 papers in Cardiology and Cardiovascular Medicine and 16 papers in Surgery. Recurrent topics in Silvia Rollefstad's work include Rheumatoid Arthritis Research and Therapies (39 papers), Spondyloarthritis Studies and Treatments (22 papers) and Lipoproteins and Cardiovascular Health (16 papers). Silvia Rollefstad is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (39 papers), Spondyloarthritis Studies and Treatments (22 papers) and Lipoproteins and Cardiovascular Health (16 papers). Silvia Rollefstad collaborates with scholars based in Norway, United States and United Kingdom. Silvia Rollefstad's co-authors include Anne Grete Semb, Eirik Ikdahl, Tore K Kvien, Grunde Wibetoe, Inge Christoffer Olsen, Cynthia S. Crowson, Jonny Hisdal, Sella Aarrestad Provan, George D. Kitas and Anne M Kerola and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and European Heart Journal.

In The Last Decade

Silvia Rollefstad

57 papers receiving 1.2k citations

Peers

Silvia Rollefstad
Tracey E. Toms United Kingdom
Mike J. Peters Netherlands
Alexandra N. Colebatch United Kingdom
Ingrid Avalos United States
B. A. C. Dijkmans Netherlands
Tracey E. Toms United Kingdom
Silvia Rollefstad
Citations per year, relative to Silvia Rollefstad Silvia Rollefstad (= 1×) peers Tracey E. Toms

Countries citing papers authored by Silvia Rollefstad

Since Specialization
Citations

This map shows the geographic impact of Silvia Rollefstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Rollefstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Rollefstad more than expected).

Fields of papers citing papers by Silvia Rollefstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Rollefstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Rollefstad. The network helps show where Silvia Rollefstad may publish in the future.

Co-authorship network of co-authors of Silvia Rollefstad

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Rollefstad. A scholar is included among the top collaborators of Silvia Rollefstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Rollefstad. Silvia Rollefstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikdahl, Eirik, Sella Aarrestad Provan, Inger Jorid Berg, et al.. (2023). Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis. Blood Pressure. 32(1). 2205956–2205956. 3 indexed citations
2.
Kerola, Anne M, Silvia Rollefstad, Grunde Wibetoe, et al.. (2022). Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scandinavian Journal of Rheumatology. 52(1). 42–50. 19 indexed citations
3.
Kerola, Anne M, Grunde Wibetoe, Silvia Rollefstad, et al.. (2021). POS0029 INCIDENCE AND TREATMENT PENETRATION OF RHEUMATOID ARTHRITIS IN NORWAY – A NATIONWIDE REGISTER LINKAGE STUDY. Annals of the Rheumatic Diseases. 80. 219–220. 1 indexed citations
4.
Kerola, Anne M, Joseph Sexton, Grunde Wibetoe, et al.. (2021). Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Seminars in Arthritis and Rheumatism. 51(5). 1081–1088. 15 indexed citations
5.
Ikdahl, Eirik, Silvia Rollefstad, Birgitte Nellemann, et al.. (2020). THU0123 DIABETES MELLITUS AND CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A LARGE INTERNATIONAL AUDIT. Annals of the Rheumatic Diseases. 79. 276–277. 1 indexed citations
6.
Semb, Anne Grete, Eirik Ikdahl, Grunde Wibetoe, Cynthia S. Crowson, & Silvia Rollefstad. (2020). Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nature Reviews Rheumatology. 16(7). 361–379. 139 indexed citations
8.
Provan, Sella Aarrestad, Silvia Rollefstad, Eirik Ikdahl, et al.. (2019). Biomarkers of cardiovascular risk across phenotypes of osteoarthritis. BMC Rheumatology. 3(1). 33–33. 5 indexed citations
9.
Sveaas, Silje Halvorsen, Annelie Bilberg, Inger Jorid Berg, et al.. (2019). High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. British Journal of Sports Medicine. 54(5). 292–297. 118 indexed citations
11.
Wibetoe, Grunde, Eirik Ikdahl, Silvia Rollefstad, et al.. (2017). Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases. International Journal of Cardiology. 252. 201–206. 2 indexed citations
12.
Thomsen, Thordis, Mikkel Østergaard, Robin Christensen, et al.. (2017). The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial. Trials. 18(1). 570–570. 16 indexed citations
13.
Crowson, Cynthia S., Silvia Rollefstad, George D. Kitas, et al.. (2017). Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS ONE. 12(3). e0174656–e0174656. 44 indexed citations
14.
Ikdahl, Eirik, Silvia Rollefstad, Jonny Hisdal, et al.. (2016). Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study. PLoS ONE. 11(4). e0153440–e0153440. 15 indexed citations
15.
Ikdahl, Eirik, Silvia Rollefstad, Grunde Wibetoe, et al.. (2016). Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 43(9). 1622–1630. 49 indexed citations
16.
Semb, Anne Grete & Silvia Rollefstad. (2016). CVD prevention and statin therapy in ankylosing spondylitis. Nature Reviews Rheumatology. 12(8). 441–442. 2 indexed citations
17.
Midtbø, Helga, Eva Gerdts, Tore K Kvien, et al.. (2016). The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. Blood Pressure. 25(5). 298–304. 19 indexed citations
18.
19.
Semb, Anne Grete, Silvia Rollefstad, Piet L. C. M. van Riel, et al.. (2014). Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice. Annals of the Rheumatic Diseases. 73(7). 1284–1288. 40 indexed citations
20.
Rollefstad, Silvia, et al.. (2012). Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Annals of the Rheumatic Diseases. 72(12). 1968–1974. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026